Quinapril/Hydrochlorothiazide Tablet shortage
Current 6 presentations · 2 manufacturers · first FDA posting Jan 19, 2023 · last update Oct 2, 2026
Manufacturers: Aurobindo Pharma USA, Chartwell Molecular Holdings LLC
Stated reasons (per FDA): Discontinuation of the manufacture of the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Jan 19, 2023 Updated Oct 2, 2026 |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Jan 19, 2023 Updated Oct 2, 2026 |
| Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90) | Aurobindo Pharma USA | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Jan 19, 2023 Updated Oct 2, 2026 |
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Jan 19, 2023 Updated Oct 2, 2026 | |
| Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Jan 19, 2023 Updated Oct 2, 2026 | |
| Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90) | Chartwell Molecular Holdings LLC | Current Available |
— | Posted Jan 19, 2023 Updated Oct 2, 2026 |